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RESEARCH NOTE
Authentication of a novel antibody 
to zebrafish collagen type XI alpha 1 chain 
(Col11a1a)
Jonathon C. Reeck1†, Makenna J. Hardy2†, Xinzhu Pu3, Cynthia Keller‑Peck3 and Julia Thom Oxford1*  
Abstract 
Objective: Extracellular matrix proteins play important roles in embryonic development and antibodies that specifi‑
cally detect these proteins are essential to understanding their function. The zebrafish embryo is a popular model for 
vertebrate development but suffers from a dearth of authenticated antibody reagents for research. Here, we describe 
a novel antibody designed to detect the minor fibrillar collagen chain Col11a1a in zebrafish (AB strain).
Results: The Col11a1a antibody was raised in rabbit against a peptide comprising a unique sequence within the 
zebrafish Col11a1a gene product. The antibody was affinity‑purified and characterized by ELISA. The antibody is 
effective for immunoblot and immunohistochemistry applications. Protein bands identified by immunoblot were 
confirmed by mass spectrometry and sensitivity to collagenase. Col11a1a knockout zebrafish were used to confirm 
specificity of the antibody. The Col11a1a antibody labeled cartilaginous structures within the developing jaw, con‑
sistent with previously characterized Col11a1 antibodies in other species. Col11a1a within formalin‑fixed paraffin‑
embedded zebrafish were recognized by the antibody. The antibodies and the approaches described here will help to 
address the lack of well‑defined antibody reagents in zebrafish research.
Keywords: Collagen α1(XI), Col11a1a, Cartilage, Zebrafish, Antibody authentication, Immunoblot, 
Immunofluorescence microscopy
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Introduction
Extracellular matrix (ECM) plays key roles during embry-
onic development [1–5], and the minor fibrillar collagens 
play regulatory roles in collagen assembly and structural 
integrity of tissues [6–11]. While in  situ hybridization 
demonstrates location of mRNA, it does not always indi-
cate the location of the resulting protein [6, 8], particu-
larly for secreted ECM proteins with long half-lives.
Collagen type XI is a trimeric molecule consisting of 
α1, α2, and α3 chains. The α1(XI) and α2(XI) chains pos-
sess unique amino terminal domains (NTD) that contain 
amino propeptides and variable regions, that are retained 
at the surface of collagen fibrils for extended periods of 
time. Collagens persist in tissues [12, 13], and undergo 
modifications such as alternative splicing of the primary 
transcript, proteolytic cleavage of the procollagen, glyco-
sylation and crosslinking [14, 15] adding to complexity. In 
this case, antibodies are essential tools to monitor spati-
otemporal changes [12, 16].
The structure of collagens presents a challenge for 
accessing epitopes for immunolocalization. Sequence 
conservation among collagens increases the challenge 
associated with the design and development of spe-
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fibrillar collagens offers attractive targets for specific pro-
tein recognition [11, 16, 19, 20]. The location and slow 
proteolytic processing make the NTD a suitable epitope 
target for antibody-based detection.
While zebrafish offer many advantages, including opti-
cal transparency and ex utero development [21, 22], one 
limitation is the paucity of antibodies for zebrafish ECM 
research. We describe antigen selection and antibody 
development of a novel Col11a1a antibody. Antibody val-




This study was performed under Boise State Univer-
sity (AC18-014 and AC18-15). Zebrafish (AB, Zebrafish 
International Resource Center (ZIRC Eugene, Oregon, 
USA; zebrafish.org) were housed under standard con-
ditions [26]. Developmental staging was reported as 
hours post-fertilization (hpf) at 28.5  °C. Embryos were 
raised to 24–72 hpf in egg water (pH 7.2) [26]. Homozy-
gous CRISPR/Cas9-generated knockout of Col11a1a 
was lethal in the majority of offspring [18]; therefore, 
heterozygous crosses were used to generate embryos to 
validate antibody. Embryos were humanely euthanized 
at 24–72 hpf on ice for 30  min followed by tricaine for 
10 min, frozen, then fixed in 4% paraformaldehyde (PFA). 
No animals were excluded. Potential confounders were 
not controlled. A total of 105 embryos were used, the 
minimum number to allow detection of protein.
Antibody design and development
Antibodies were generated using the peptide sequence 
 NH2-ck(g)9dvphkdtlqa-COOH conjugated to keyhole 
limpet hemocyanin. Custom primary antibody pro-
duction was outsourced to Bethyl Laboratories, Inc., 
Montgomery, Texas USA (bethyl.com). Rabbits were 
immunized and sera were collected. Sequential bleeds 
were screened by ELISA against the peptide to determine 
titer. Rabbits were euthanized according to ethical use 
protocols held by Bethyl Laboratories. Antibodies were 
affinity purified, concentrated to 5 mg/mL, and stored at 
− 20 °C.
Protein isolation and detection by immunoblot
Wildtype, heterozygotes  (Col11a1a+/−) and homozy-
gotes  (Col11a1a−/−) embryos were used for protein 
isolation and detection. Experimental groups con-
tained 20 embryos. Embryos were dechorionated using 
1 mg/mL pronase at room temperature then rinsed in 
Ringer’s solution. Embryos were treated with ethylen-
ediamine tetraacetic acid and protease/phosphatase 
inhibitor cocktail (Thermo Fisher Scientific) in Ring-
er’s and passed through a glass pipette to remove the 
yolk.
Samples were processed as previously described [27] 
with modification. In brief, samples previously fixed 
in 4% paraformaldehyde (PFA) were incubated in 2% 
sodium dodecyl sulfate (SDS) at 95  °C for 30  min and 
60 °C for 2 h to reverse PFA fixation. The embryos were 
centrifuged for 20  min at 5000×g and the supernatant 
was removed. De-yolked embryos were homogenized in 
SDS sample buffer with a microfuge pestle, boiled, centri-
fuged to clarify, and proteins were separated on a 4–12% 
gradient bis–Tris gel. After transfer to polyvinylidene 
difluoride membranes, they were blocked for 60  min at 
room temperature. Membranes were rinsed with Tween-
20 Tris buffered saline (TTBS) 3 × 5  min. Primary anti-
body was added to the membrane at a 1:1000 dilution 
in TTBS with 5% bovine serum albumin and incubated 
overnight at 4  °C with constant rocking. For peptide 
blocking experiments, the peptide was added to the pri-
mary antibody solution and agitated for 1 h before add-
ing to the membrane. The primary antibody solution 
was decanted, and unbound antibody was removed by 
rinsing the membrane with TTBS 3 × 5  min. Second-
ary antibody conjugated to horseradish peroxidase was 
added to the membrane and rocked at room temperature 
for one hour. The secondary antibody was decanted, and 
the membrane washed 3 × 5  min with TTBS. Enhanced 
chemiluminescence reagent was added to the mem-
brane. Imaging and quantification was performed on a 
FluorChem E Digital Darkroom. Mean intensity plus and 
minus standard deviation was reported, N = 3 independ-
ent replicates.
Liquid chromatography–tandem mass spectrometry (LC–MS/
MS)‑based protein sequence analysis
LC–MS/MS analysis was performed using methods 
established previously [28] with modifications. Briefly, 
excised gel pieces were destained in 50% acetonitrile 
and 50  mM  NH4HCO3, followed by the treatment with 
dithiothreitol (10  mM) to reduce disulfide bonds and 
iodoacetamide (55 mM) for alkylation and then digested 
with proteomics grade trypsin (Thermo Fisher Scientific, 
Waltham, MA, USA) overnight at 37  °C. Peptides were 
extracted, dried under vacuum, and reconstituted in 5% 
acetonitrile and 0.1% formic acid. Tryptic peptides were 
analyzed on a Velos Pro Dual-Pressure Linear Ion Trap 
mass spectrometer equipped with a nano electrospray 
ionization source and coupled with an Easy-nLC II nano 
LC system (Thermo Fisher Scientific).
Peptide spectral matching and protein identification 
were achieved by database search using Sequest HT 
algorithms in Proteome Discoverer 2.2 (Thermo Fisher 
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Scientific). Raw spectrum data were searched against the 
UniProtKB/Swiss-Prot protein database for Zebrafish 
(downloaded from www. unipr ot. org on 9/8/20). Search 
parameters included: trypsin, maximum missed cleavage 
site of two, precursor mass tolerance of 1.5 Da, fragment 
mass tolerance of 0.8  Da, fixed modification of cysteine 
carbamidomethylation (+ 57.021 Da), and variable modi-
fication of oxidation/hydroxylation of methionine, pro-
line, and lysine (+ 15.995  Da). Decoy database search 
was performed to calculate false discovery rate (FDR). 
Proteins containing two or more peptides with FDR 
≤ 0.01were considered positively identified.
Immunofluorescence
Zebrafish embryos were fixed in 4% PFA and embedded 
in paraffin prior to sectioning. Samples were cut into 
10  µm sections. Sections were deparaffinized in His-
toclear  and rehydrated in a graded alcohol series. Sec-
tions were rinsed with 0.1% Tween-20 in PBS and Triton 
X-100 at room temperature. Blocking was performed in 
5% goat serum and 2% Tween-20 in PBS for 1 h. Primary 
antibodies were diluted in blocking solution at 1:1000 
and samples were incubated at 4  °C overnight. Second-
ary antibody was diluted 1:200 in blocking solution and 
applied to samples overnight in the dark. Prolong™ Gold 
antifade mountant with 4ʹ,6-diamidino-2-phenylindole 
(DAPI) (Fisher Scientific) was used to mount the cover-




We identified a unique sequence within the zebrafish col-
lagen α1(XI) protein corresponding to the NTD [29–31]. 
This sequence is encoded by exon 5, preceding the start 
of the variable region (Fig. 1).
Immunoblot analysis
We tested the specificity of the antibody against protein 
extracted from whole zebrafish lysates by immunoblot. 
The antibody recognized protein bands with apparent 
molecular weights of 100 kilodaltons (kDa) and 35  kDa 
from total lysate collected from embryos at 24 hpf cor-
responding to fragments of Col11a1a without recogniz-
ing full-length Col11a1a under experimental conditions 
used. Collagenase treatment of an ECM extract resulted 
in the depletion of the 100 kDa band and a concomitant 
generation of a protein band with an apparent molecu-
lar weight of 35  kDa (Fig.  2A). Specificity for Col11a1a 
was also demonstrated by immunoblot using pro-
teins extracted from wildtype, heterozygous ( +/−, and 
homozygous (−/−) knockout animals (Fig. 2B).
The antibody recognized the peptide originally used to 
generate the antibody under the conditions of the immu-
noblot, as indicated by observed competition by the pep-
tide and abolition of the detection of protein bands at 
100 kDa and 35 kDa (Fig. 2A).
Protein sequence analysis
The protein bands identified by immunoblot were excised 
and submitted for mass spectrometry to confirm identity 
of the proteins by sequencing (Fig. 2B and C). Mass spec-
trometry results of the band migrating with an apparent 
molecular weight of 100 kDa identified peptides from the 
NTD of Col11a1a. The NTD peptides were also identified 
in a band with an apparent molecular weight of 35 kDa 
(Fig. 2C and D).
Specificity of Col11a1a antibody
To confirm antibody specificity, we tested the antibody 
on proteins extracted from Col11a1a knockout zebrafish. 
Immunoblot indicated a lower expression of Col11a1a in 
heterozygous embryos and no expression in knockout 
homozygous embryos. Fragment (100 kDa) and very low 
levels of full length Col11a1a were observed in wildtype 
and heterozygous embryos while knockout embryos dis-
played no Col11a1a protein expression (Fig. 2E).
Immunohistochemistry
We confirmed that the antibody recognized tissues 
in which expression of collagen type XI is known to 
occur including the mandible, Meckel’s cartilage, and 
Fig. 1 Model of Collagen type XI. A Collagen type XI molecule. Structural regions of the type XI collagen molecule are indicated including the 
signal peptide, amino terminal propeptide, variable region, the minor helix, the amino telopeptide, the major triple helix, the carboxy telopeptide, 
and the carboxy propeptide. Relative size and dimensions are shown above the molecular model. B Three alpha chains: α1(XI), α2(XI), and α3(XI). 
C Formation of triple helical molecule is initiated at the C‑terminus. D Fully assembled triple helical collagen molecule with carboxyl propeptide. 
E Potential cleavage events, with carboxy propeptide removed, with amino propeptide removed at the BMP‑1 cleavage site (35 kDa), and finally, 
with the ADAMTS2 cleavage site within the amino telopeptide indicated by the vertical dotted line that would release the major triple helix and 
generate a fragment containing the amino propeptide and variable region (100 kDa). F Exon structure of Col11a1a, indicating alternatively spliced 
isoforms. G Epitope sequence unique to the new antibody. This sequence is encoded by exon 5 which is present in all spliceforms. NTD amino 
terminal domain, Npp amino propeptide domain, VR variable region, mh minor helix, N-tp amino telopeptide, MH major triple helix, C-tp carboxy 
telopeptide, Cpp carboxy propeptide
(See figure on next page.)
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eye structures at 72 hpf (Fig. 3). Specificity was demon-
strated by the absence of staining in the negative controls 
using pre-immune serum or in the absence of primary 
antibody.
Discussion
Collagens are essential for establishing tissue morphol-
ogy during embryological development. Our goal was to 
develop an antibody recognizing Col11a1a of zebrafish. 
We chose an epitope that was unique to zebrafish 
Col11a1a within the NTD of Col11a1a that could be used 
for both immunoblotting and immunohistochemistry. 
The detection of a protein migrating with an apparent 
molecular weight of 100  kDa is consistent with a frag-
ment generated by proteolytic cleavage by A Disintegrin 
And Metalloproteinase With Thrombospondin Motifs 2 
(ADAMTS2) within the amino telopeptide [31, 32]. The 
recognition of the 35 kDa protein band is consistent with 
a released NTD fragment upon collagenase digestion to 
remove the minor helix or alternatively, proteolytic pro-
cessing by bone morphogenetic protein-1 (BMP-1) [31, 
33, 34]. Together, these results support the utility of the 
new antibody to recognize biologically relevant forms of 
Col11a1a in the zebrafish embryo.
Mass spectrometry identified peptides unique to 
Col11a1a in bands identified by the new antibody, sup-
porting future investigations of collagens during devel-
opment [35, 36]. Important aspects of the molecular 
processing of procollagens that results in mature col-
lagens [37, 38] and the fates of fragments [39] may be 
revealed using this antibody. Additionally, this antibody 
may facilitate the localization of collagens in tissues 
such as skin, bones, and ligaments [40–43]. The epitope 
recognized by the new antibody is unique to zebrafish 
Col11a1a and the antibody did not recognize other col-
lagen types. Immunoblot analysis of Col11a1a knockouts 
confirmed specificity of the Col11a1a antibody.
Tissue staining within the eye and craniofacial cartilage 
of the jaw at 72 hpf is consistent with results from other 
species [40]. The Col11a1 chondrodystrophic (cho) mouse 
is characterized by deficiencies in craniofacial chondro-
genesis [40, 44]. Human disorders such as type 2 Stickler 
syndrome due to a mutation in COL11A1, display a small 
jaw, high myopia, and retinal detachment [18, 45–47].
Fig. 2 Antibody detection of Col11a1a protein by immunoblot and confirmed by mass spectrometry. A The antibody recognized protein bands 
migrating with apparent molecular weights of 100 and 35 kDa from 24 hpf zebrafish total lysate. Proteins extracted from the ECM contained the 
100 kDa that was converted to a 35 kDa band upon treatment with collagenase. In the presence of a large excess of the peptide used as the 
antigen, the 100 kDa and 35 kDa bands from total lysate are not visible on the immunoblot, indicating competition by the peptide for the antigen 
binding site on the antibody. See Addiitonal file 1: Figure S1 for full length original unprocessed blots. B Representative immunoblot of proteins 
extracted from wildtype, heterozygous, and homozygous knockout zebrafish. The 100 kDa fragment of Col11a1a is apparent in lysate from 72 hpf 
zebrafish with quantitatively minor bands at the position of full‑length Col11a1a. C Structural model of the amino propeptide domain of Col11a1a. 
Peptides detected by mass spectrometry are indicated in their respective locations of the exons encoding the protein. D Protein sequence of 
Col11a1a amino propeptide domain with grey shading indicates the sequence coverage used to confirm the identity of the protein recognized 
by the new antibody as Col11a1a. E Quantification of immunoblot band intensity from proteins extracted from wildtype (WT), heterozygotes, 
and homozygous knockout embryos. The NTD fragment and full‑length molecule were quantified from three individual blots by densitometry, 
calculating average and standard deviation. Absence of these protein bands from homozygous knockout embryos confirmed specificity of the new 
antibody. WT wildtype, HET heterozygous, KO knockout, MW molecular weight markers
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Collagen type XI nucleates and limits the diameter of 
collagen type II fibrils and interacts with non-collagenous 
molecules. Previous studies demonstrated severe changes 
in the ECM and collagen networks when Col11a1a was 
knocked down in zebrafish [1, 18]. Additionally, Col11a1 
mutations in the cho mouse show disordered chondro-
cytes and collagen fibrils in the growth plate [40–43].
We have generated a novel tool for monitoring changes in 
Col11a1a synthesis and localization in zebrafish tissue. We 
show that the antibody is useful for immunoblot and immu-
nohistochemistry and confirmed the expression in cartilage 
of the developing skeleton as expected for collagen type 
XI. Future studies will rely on this antibody to investigate 
zebrafish models of human diseases related to COL11A1.
Limitations
• Additional collagens migrated with apparent molecu-
lar weight (MW) of approximately 100  kDa specifi-
cally, collagen XIIα1, however, this collagen does not 
contain the epitope.
• Homozygous and heterozygous offspring were sep-
arated based on severity of observed phenotype. It 
is possible that some more severely affected het-
erozygotes were classified as homozygotes, leading 
to low levels of Col11a1a present in protein extracts 
from the homozygous knockout group. However, 
based on original homozygous embryo data before 
outcrossing, we feel confident in our ability to dis-
tinguish homozygous knockouts from heterozy-
gotes.
• It is unclear how efficiently the antibody recognizes 
full-length Col11a1a, due low levels of protein pre-
sent. Patterns of expression may change over time 
as the embryo matures.
Abbreviations
ADAMTS2: A disintegrin and metalloproteinase with thrombospondin motifs 
2; BMP‑1: Bone morphogenetic protein ‑1; cho: Chondrodystrophic; DAPI: 4ʹ,6‑
Diamidino‑2‑phenylindole; ECM: Extracellular matrix; ELISA: Enzyme‑linked 
immunosorbent assay; FDR: False discovery rate; Hpf: Hours post‑fertilization; 
Fig. 3 Immunohistochemistry demonstrating location of Col11a1a within developing craniofacial region at 72 hpf. Wildtype zebrafish embryos 
were fixed, embedded, and sectioned for immunofluorescence detection of Col11a1a using the new primary antibody. A Schematic representation 
of the craniofacial region of zebrafish. B Negative control using pre‑immune serum in place of primary antibody. C Negative control omitting 
primary antibody. D Col11a1a primary antibody (green) detects Col11a1a in the eye and within the jaw cartilage elements represented by the 
mandible (ma) and Meckel’s cartilage (mc). DAPI (blue) staining indicates the location of cell nuclei. Dotted square frames indicate location of higher 
magnification images of mandibular cartilage shown in E and Meckel’s cartilage shown in F. Scale bars B 50 µm; C 50 µm; D 50 µm; E 250 µm; F 
250 µm. Results are representative of staining pattern found in 15 individual embryos
Page 7 of 8Reeck et al. BMC Res Notes          (2021) 14:359  
IACUC : Institutional Animal Care and Use Committee; kDa: Kilodaltons; LC–MS/
MS: Liquid chromatography tandem mass spectrometry; MW: Molecular 
weight; NTD: Amino terminal domain; PFA: Paraformaldehyde; SDS: Sodium 
dodecyl sulfate; TTBS: Tween‑20 Tris buffered saline.
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Additional file 1: Figure S1. Full‑length lanes from unprocessed images 
of immunoblots. (A) Immunoblot of total lysate from zebrafish embryos 
with Col11a1a antibody. Lane 1—2. 24 hpf embryo protein extract, 10 
μg and 5 μg total protein loaded onto gel, respectively. (B) Immunoblot 
of extracellular matrix extract of 24 hpf embryos, 10 μg of total protein 
loaded onto gel. Lane 1. Col11a1a prior to collagenase treatment (minus 
collagenase (coll’ase)) showing 100 kDa bond. Lane 2. Col11a1a after 
collagenase treatment (plus collagenase (coll’ase)) showing 35 kDa 
band. (C) Immunoblot demonstrating antibody specificity to Col11a1a 
epitope. Lane 1. Col11a1a peptide loaded onto gel and recognized by 
antibody. Lane 2. Sample depleted of epitope‑containing proteins prior 
to loading onto gel for immunoblot. (D) Lane 1. 24 hpf embryo protein 
extract (shown in panel A), incubated in the presence of antibody plus 
a large excess of immunogenic peptide (shown in panel C). The peptide 
competes for antibody binding to the Col11a1a‑related polypeptides on 
the blot.
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